Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.

PLoS One · 2014 · PMC4118967 · PMID 25084453

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significancep = 0.054so close (0.05 < p ≤ 0.1)

However, the O+B co-treatment reduced the pAMPKα protein level compared with olanzapine-only treatment at a borderline significance (−22%, p = 0.054; Figure 4A and D ).

also in 4,352 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.